Literature DB >> 12195715

A 4% solution of bovine serum albumin may be used in place of factor VIII:C deficient plasma in the control sample in the Nijmegen Modification of the Bethesda factor VIII:C inhibitor assay.

Bert Verbruggen, Waander van Heerde, Irena Novákovà, David Lillicrap, Alan Giles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12195715

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  6 in total

1.  Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance.

Authors:  C H Miller; S J Platt; A S Rice; F Kelly; J M Soucie
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

2.  Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen-Bethesda assay for factor VIII inhibitors.

Authors:  C H Miller; A B Payne; J Driggers; D Ellingsen; B Boylan; C J Bean
Journal:  Haemophilia       Date:  2018-03-24       Impact factor: 4.287

Review 3.  Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review.

Authors:  C H Miller
Journal:  Haemophilia       Date:  2018-02-15       Impact factor: 4.287

Review 4.  Characterization of factor VIII inhibitors.

Authors:  Midori Shima
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

Review 5.  Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature.

Authors:  Sébastien Sanges; Emmanuelle Jeanpierre; Benjamin Lopez; Jules Russick; Sandrine Delignat; Benjamin Carpentier; Romain Dubois; Sylvain Dubucquoi; Thomas Guerrier; Éric Hachulla; Pierre-Yves Hatron; Camille Paris; Sophie Susen; David Launay; Sébastien Lacroix-Desmazes; Louis Terriou
Journal:  Front Immunol       Date:  2020-12-18       Impact factor: 7.561

6.  Genetic variants at the chromosomal region 2q21.3 underlying inhibitor development in patients with severe haemophilia A.

Authors:  Silvia Spena; Andrea Cairo; Emanuela Pappalardo; Marcin M Gorski; Isabella Garagiola; Shermarke Hassan; Roberta Gualtierotti; Flora Peyvandi
Journal:  Haemophilia       Date:  2022-02-19       Impact factor: 4.263
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.